MiNK Therapeutics, Inc. (INKT) Misses Q4 EPS by 54c

MiNK Therapeutics, Inc. (NASDAQ: INKT) reported Q4 EPS of ($0.62), $0.54 worse than the analyst estimate of ($0.08).

For earnings history and earnings-related data on MiNK Therapeutics, Inc. (INKT) click here.

You May Also Be Interested In

• Micron offers Taiwan workers up to 68-month bonuses as strike threat looms
• 0.4%+ MoM on Core CPI would be a 'gamechanger' for the Fed: Citi
• CPI (Aug YoY) 3.4% vs 3.4% Expected; Ex-food and Energy 2.4% vs 2.4%